MINI THANNIKAL: Open Payments
NPI 1982038295 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 19 payments from 9 companies in 2025. Trend: 2023 $433 · 2024 $648 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $159 |
| SCPHARMACEUTICALS INC. | 3 | $102 |
| E.R. Squibb & Sons, L.L.C. | 2 | $77 |
| Alnylam Pharmaceuticals Inc. | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Advanced Oxygen Therapy Inc. | 1 | $45 |
| Kestra Medical Technology Services, Inc. | 1 | $40 |
| AtriCure, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
Products named: General - Therapies, FUROSCIX, ONPATTRO, Topical Oxygen Chamber for extremities, Assure WCD, CAMZYOS, ATRICLIP LAA EXCLUSION SYSTEM, JARDIANCE.
Industry payments across NY — which companies pay providers there.
